MedTrace Logo

Early Venous Reflux Ablation Ulcer Trial

NCT03286140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2024-05-20

Study results available
· View outcomes & findings →

Summary

The EVRA study evaluates the effects of early endovenous ablation on ulcer healing in patients with chronic venous ulceration. Half the patients are randomised to receive early endovenous ablation (within 2 weeks) and half to standard care

Conditions

  • Venous Leg Ulcer

Interventions

PROCEDURE

Early endovenous ablation

PROCEDURE

Delayed endovenous intervention

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER

  • Universidad de Granada

    collaborator OTHER

  • University of Manchester

    collaborator OTHER

  • University of Warwick

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Gerard Stansby · Newcastle University

  • Julie Brittenden · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03286140 on ClinicalTrials.gov